XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses        
Research and development $ 73,744 $ 45,404 $ 149,921 $ 85,741
General and administrative 18,324 10,505 37,914 20,726
Total operating expenses 92,068 55,909 187,835 106,467
Loss from operations (92,068) (55,909) (187,835) (106,467)
Interest income 1,135 81 1,211 230
Interest expense (5) (5) (10) (11)
Other income (expense), net 310 (19) 297 (51)
Net loss $ (90,628) $ (55,852) $ (186,337) $ (106,299)
Net loss per common share, basic $ (1.74) $ (1.08) $ (3.57) $ (2.06)
Net loss per common share, diluted $ (1.74) $ (1.08) $ (3.57) $ (2.06)
Weighted Average Number of Shares Outstanding, Basic 52,218,773 51,573,894 52,195,972 51,644,946
Weighted Average Number of Shares Outstanding, Diluted 52,218,773 51,573,894 52,195,972 51,644,946
Other comprehensive income (loss)        
Change in unrealized losses related to available-for-sale debt securities, net of tax $ (1,869) $ (18) $ (1,869) $ (53)
Total other comprehensive income (loss) (1,869) (18) (1,869) (53)
Comprehensive loss $ (92,497) $ (55,870) $ (188,206) $ (106,352)